Zobrazeno 1 - 10
of 206
pro vyhledávání: '"M. Sandberg-Wollheim"'
Autor:
Elke Theander, E. Bodil Roth, Anna-Maria Larsson, Pål Stenberg, Klas Sjöberg, M. Sandberg-Wollheim, E. Londos
Publikováno v:
Scandinavian Journal of Immunology. 67:626-631
Coeliac disease (CD) is becoming a model for understanding the pathogenesis of autoimmune disorders. In CD, antibodies against transglutaminase 2 (TG2) and specific residues of gliadins have been identified. A similar situation is seen in rheumatoid
Autor:
MS Freedman, LD Blumhardt, B. Brochet, G. Comi, JH Noseworthy, M. Sandberg-Wollheim, P. Soelberg Sørensen
Publikováno v:
Multiple Sclerosis Journal. 8:19-23
Objective:To provide recommendations on the use of disease-modifying agents in the management of multiple sclerosis (MS) and to ensure that treatment will be available to those patients who may benefit.Methods:An initial draft of the consensus statem
Autor:
M. Bergkvist, M. Sandberg‐Wollheim
Publikováno v:
Acta Neurologica Scandinavica. 104:262-265
Objectives– The etiology of MS is unknown but genetic factors are supported by a high concordance in twins. Geographic distribution and migration studies indicate, however, the importance of environmental factors. Material and methods– We studied
Publikováno v:
Annals of the Rheumatic Diseases. 60:791-795
Objective—To study the association between rheumatoid arthritis (RA) and HLA and tumour necrosis factor (TNF) polymorphism in Peruvian mestizo patients in comparison with ethnically similar controls. Methods—Seventy nine patients with RA and 65 e
Publikováno v:
Scandinavian journal of clinical and laboratory investigation. 63(6)
Prolyl endopeptidase (EC 3.4.21.26) (PEP) is present in nearly all investigated mammalian cells and biological fluids and might be involved in the degradation of physiologically important neuropeptides. To be able to investigate the variation of PEP
Autor:
Reinhard Hohlfeld, M. Clanet, Ludwig Kappos, M. F. Kooijmans-Coutinho, E. W. Radue, Hans-Peter Hartung, E. C. Tsao, A. W. Sandrock, M. Sandberg-Wollheim
Publikováno v:
Neurology. 59(10)
Interferon beta-1a (IFNbeta-1a; Avonex) is effective for the treatment of relapsing MS; however, the optimal dose of IFNbeta-1a is not known.To determine whether IFNbeta-1a 60 micro g IM once weekly is more effective than IFNbeta-1a 30 micro g IM onc
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 1
Two multicenter, randomized, double-blind, placebo-controlled phase III studies to evaluate the safety and efficacy of 6 and 12 MIU of recombinant human interferon beta (r-hIFN-beta) (Rebif) given subcutaneously three times per week, in patients with
Autor:
Clara Milanese, M. Sandberg-Wollheim, R. Parma, Angelo Nespolo, Bo Baldetorp, Andrea Salmaggi
Publikováno v:
Acta neurologica Scandinavica. 84(2)
Five patients with chronic progressive multiple sclerosis (MS) and three control patients with lumbar disc herniation were treated with dexamethazone during 14 days. The effect on peripheral blood T-cell subsets and on the proliferative response of p
Autor:
M, Sandberg-Wollheim, P, Malmström, L G, Strömblad, H, Anderson, S, Borgström, A, Brun, S, Cronqvist, K, Hougaard, L G, Salford
Publikováno v:
Cancer. 68(1)
The authors undertook a controlled, prospective, randomized study of 171 patients with supratentorial astrocytoma grades 3 and/or 4 (classified according to Kernohan). All patients were given chemotherapy consisting of procarbazine, vincristine, and
Publikováno v:
Annals of neurology. 27(4)
Eighty-six patients with monosymptomatic optic neuritis of unknown cause were followed prospectively for a median period of 12.9 years. At onset, cerebrospinal fluid (CSF) pleocytosis was present in 46 patients (53%) but oligoclonal immunoglobulin in